Back

When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation?: A multi-center prospective randomized study

17 March 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Moderated ePosters 3: atrial fibrillation ablation: dealing with gaps and safety Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2019

About the speaker

Photo
Associate Professor Hee Tae Yu

Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul (Korea (Republic of))

7 More presentations in this session

Presentation thumbnail
Predictors of long-term outcome in patients undergoing a first repeat ablation for atrial fibrillation consisting solely of re-isolation of reconnected pulmonary veins.
Doctor J. Abugattas (Namur, BE)
Abstract Slides
Presentation thumbnail
Epicardial connections between right pulmonary veins and the right atrium. Relevance for effective ablation
Doctor D. Calvo Cuervo (Madrid, ES)
Abstract Slides
Presentation thumbnail
Accuracy of the late gadolinium enhancement cardiac magnetic resonance in the identification of electrical reconnections of veins in atrial fibrillation repeated ablation procedures
Miss J. COZZARI (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Pilot study evaluating MRI parameters for prediction of ablation induced esophageal injury after atrial fibrillation ablation
Doctor P. Halbfass (Oldenburg, DE)
Abstract Slides
Presentation thumbnail
Echo-endoscopic evaluation of the esophagus after enclosing the pulmonary veins with contiguous and optimized RF lesions
Doctor M. Wolf (Antwerp, BE)
Abstract Slides

Access the full session

Session thumbnail
Moderated ePosters 3: atrial fibrillation ablation: dealing with gaps and safety

The Event

Event poster

EHRA 2019

17 March - 19 March 2019

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources